Navigation Links
Romark Laboratories Raises $18 Million in Institutional Financing
Date:12/21/2007

TAMPA, Fla., Dec. 21 /PRNewswire/ -- Romark Laboratories, L.C., a privately-owned biotechnology company, today announced the closing of an $18 million institutional financing with the D.E. Shaw Group.

The proceeds from this financing will enable Romark to advance development of its lead compound, nitazoxanide, for the treatment of hepatitis C, and advance its next-generation thiazolide drug candidates for the treatment of hepatitis B and C and other viral diseases. Romark is currently conducting a U.S. Phase 2 trial of nitazoxanide in hepatitis C patients who have failed standard treatments, and expects to begin a U.S. Phase 2 trial in treatment naive patients in the first quarter of 2008.

About D.E. Shaw Group The D.E. Shaw group (http://www.deshaw.com) is a global investment and technology development firm with more than 1,200 employees; approximately $35 billion in aggregate investment capital; and offices in North America, Europe, and Asia.

About Romark Laboratories

Romark Laboratories, L.C. (http://www.romark.com) is a privately-owned biotechnology company committed to the discovery and development of innovative new small molecules for treating infectious diseases, cancers, and autoimmune diseases.


'/>"/>
SOURCE Romark Laboratories, L.C.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Globus Medical Raises $110 Million in Series E Financing Round
6. EntreMed Raises $20 Million to Support Clinical Development Program
7. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
8. Atritech Announces Completion of a $22 Million Equity Financing
9. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
10. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
11. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014  Neurocrine Biosciences, Inc. ... Company will report its second quarter 2014 financial results ... 2014.  Neurocrine will then host a live conference call ... a Company update Thursday morning, August 7, 2014 at ... Participants can access the live conference call by ...
(Date:7/29/2014)... -- Sysmex America, Inc., a global leader in medical diagnostic ... exhibit booth during the American Association for Clinical ... in Chicago , July 27 through ... excited to exhibit at AACC this year, because it,s ... continue the dialogue on how to best meet the ...
(Date:7/29/2014)... , July 29, 2014 Apex Medical Corporation ... and Pressure Area Care sectors, announces that it is appealing ... in Germany that found ... Apex notes that it has initiated invalidity challenges against various ... efforts in counterattacking against trivial and junk patents. ...
Breaking Medicine Technology:Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 3Apex Continues Fighting Against Patents to Free Up Competition 2
... CPhI Worldwide and connected events - the global pharma ingredients and ... - 15 October for its 20th staging. , The co-located ... technology events are joined for 2009 under the Where Pharma ... The new platform markedly reflects the notable convergence of the pharma ...
... (Nasdaq: DYNT ) today announced the appointment of Douglas ... research and development, replacing Ronald Hatch, who has retired. , ... said Kelvyn Cullimore Jr., chairman and president of Dynatronics. "His ... operation as well as our research and development efforts here ...
Cached Medicine Technology:CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence 2CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence 3Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development 2
(Date:7/29/2014)... of America (GSA) the nation,s largest interdisciplinary ... chosen Corinna E. Lckenhoff, PhD, of Cornell University as ... B. Baltes Foundation Award in Behavioral and Social Gerontology. ... career contributions in behavioral and social gerontology. Individuals who ... are eligible. The award is given by GSA in ...
(Date:7/29/2014)... 2014 The report “Filling Equipment ... (Rotary, Volumetric, Aseptic, Net Weight), Process (Manual, Semi-Automatic, ... Global Trend & Forecast to 2019”, defines the ... beverage, pharmaceutical, and cosmetic segments with analyses and ... these segments, in terms of value. It also ...
(Date:7/29/2014)... July 29, 2014 - What if ... source? That’s the big public health question being addressed ... risk program developed by Principled Strategies . SafeUseNow ... be part of The Hive at the ... The Hive is a community of exceptional startups and ...
(Date:7/29/2014)... -- With the increasing use of electronic medical ... growing demand for a computerized version of the ... States. In a new study, researchers from the ... Institute report that substantial work lies ahead to ... guidelines into computerized prompts for physicians, but the ...
(Date:7/29/2014)... Reseda, Calif (PRWEB) July 29, 2014 ... , The Discovery House recently participated in a community ... Valley. The group of volunteers partnered with the San ... to individuals in need. , The San Fernando Valley ... individuals and families. The mission's Family Emergency Shelter provides ...
Breaking Medicine News(10 mins):Health News:Löckenhoff earns GSA's 2014 Baltes Foundation Award 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 3Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 4Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 2Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 3Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:The Discovery House Employees Volunteer at Local Rescue Mission 2Health News:The Discovery House Employees Volunteer at Local Rescue Mission 3
... News) -- It seems that Americans really can be in ... visited five car shows in Arizona and conducted interviews with ... found that those with an especially strong attachment used pet ... In addition, some people used this emotional connection to ...
... of Medicine in St. Louis have learned why changes in ... the parasite Toxoplasma gondii . The answer has likely ... Toxoplasma and many other parasites. In a ... show that the ROP18 protein disables host cell proteins that ...
... Dec. 28 (HealthDay News) -- Preteens with conduct disorders are much ... they are teens, finds a new Canadian study. It followed ... 13 at the start of the study. Those who stole, ... likely to sell illicit drugs, nine times more likely to join ...
... Reporter , TUESDAY, Dec. 28 (HealthDay News) -- Sheri Foote ... have. Foote, 43 and a Denver resident, was first ... about age 21. "I knew I had a family history ... good thing to do," Foote recalled. Her cholesterol "was ...
... PAUL, Minn. Epilepsy, a common and serious neurologic disorder that ... and funding for research it deserves, according to an editorial ... issue of Neurology, the medical journal of the ... surveillance, or ongoing collection of data on newly diagnosed epilepsy, ...
... [Brown University] A novel potential therapy based on a ... in mice who have the same genetic mutation as boys ... a paper published online Dec. 27 in the Proceedings ... Dystrophy is a fatal genetic mutation in about one of ...
Cached Medicine News:Health News:Love of Possessions Can Run Deep, Study Shows 2Health News:Protein helps parasite survive in host cells 2Health News:Woman Struggles to Control Cholesterol 2Health News:Researchers: Pay more attention to epilepsy 2Health News:Human protein improves muscle function of muscular dystrophy mice 2
... Chalam 15° Prism are designed ... are recommended for tractional retinal ... Rhegmatogenus retinal detachment. They can ... and other midperipheral laser applications. ...
... The High-Mag 1.5x ... internal limiting membrane peeling ... optic nerve neurotomy, sheathotomy ... traditional macular edema and ...
... visualization of virtually the entire retina including ... of the lens on the eye. It ... giant retinal tears, diagnosing and treating anterior ... retina in a vitreous cavity filled with ...
... higher magnification and increased stereopsis, ... suited for detailed visualization to ... Retinal is ideal for vitrectomy ... peeling in proliferative vitreoretinopathy extending ...
Medicine Products: